$BHC
Bausch Health Companies Inc.

2024 Q3 Form 10-Q Financial Statement

#000088559024000029 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.510B $2.403B
YoY Change 12.15% 10.89%
Cost Of Revenue $719.0M
YoY Change 10.79%
Gross Profit $1.684B
YoY Change 10.94%
Gross Profit Margin 70.08%
Selling, General & Admin $850.0M $832.0M
YoY Change 18.88% 17.02%
% of Gross Profit 49.41%
Research & Development $146.0M $156.0M
YoY Change -4.58% 0.0%
% of Gross Profit 9.26%
Depreciation & Amortization $318.0M
YoY Change 0.95%
% of Gross Profit 18.88%
Operating Expenses $996.0M $988.0M
YoY Change 14.75% 13.96%
Operating Profit $318.0M $389.0M
YoY Change 2171.43% -5.58%
Interest Expense -$353.0M
YoY Change 6.01%
% of Operating Profit -90.75%
Other Income/Expense, Net -$225.0M -$20.00M
YoY Change 275.0% -124.1%
Pretax Income -$21.00M $48.00M
YoY Change -93.56% -39.24%
Income Tax $71.00M $49.00M
% Of Pretax Income 102.08%
Net Earnings -$85.00M $10.00M
YoY Change -77.51% -61.54%
Net Earnings / Revenue -3.39% 0.42%
Basic Earnings Per Share -$0.23 $0.03
Diluted Earnings Per Share -$0.23 $0.03
COMMON SHARES
Basic Shares Outstanding 367.1M shares 366.8M shares
Diluted Shares Outstanding 368.4M shares 370.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $595.0M
YoY Change 2.76%
Cash & Equivalents $719.0M $595.0M
Short-Term Investments
Other Short-Term Assets $902.0M
YoY Change 0.33%
Inventory $1.655B $1.612B
Prepaid Expenses
Receivables $2.102B
Other Receivables $0.00
Total Short-Term Assets $5.351B $5.211B
YoY Change 6.0% 16.81%
LONG-TERM ASSETS
Property, Plant & Equipment $1.789B $1.738B
YoY Change 12.94% 8.69%
Goodwill $11.17B $11.13B
YoY Change -0.14% -4.31%
Intangibles $5.652B $5.903B
YoY Change -15.99% 11.4%
Long-Term Investments
YoY Change
Other Assets $389.0M $329.0M
YoY Change 18.6% 1.23%
Total Long-Term Assets $21.19B $21.28B
YoY Change -3.76% 1.15%
TOTAL ASSETS
Total Short-Term Assets $5.351B $5.211B
Total Long-Term Assets $21.19B $21.28B
Total Assets $26.54B $26.50B
YoY Change -1.94% 3.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $667.0M $579.0M
YoY Change 17.22% 12.43%
Accrued Expenses $3.386B $3.338B
YoY Change 8.56% 10.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $453.0M $452.0M
YoY Change -15.49% 1.8%
Total Short-Term Liabilities $4.506B $4.369B
YoY Change 6.68% 10.13%
LONG-TERM LIABILITIES
Long-Term Debt $21.05B $21.21B
YoY Change -3.84% 5.47%
Other Long-Term Liabilities $805.0M $745.0M
YoY Change 11.65% 0.0%
Total Long-Term Liabilities $21.86B $21.95B
YoY Change -3.34% 5.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.506B $4.369B
Total Long-Term Liabilities $21.86B $21.95B
Total Liabilities $26.78B $26.72B
YoY Change -1.89% 5.91%
SHAREHOLDERS EQUITY
Retained Earnings -$9.917B -$9.832B
YoY Change 1.83% 5.03%
Common Stock $10.69B $10.66B
YoY Change 0.75% 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.174B -$1.175B
YoY Change
Total Liabilities & Shareholders Equity $26.54B $26.50B
YoY Change -1.94% 3.89%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$85.00M $10.00M
YoY Change -77.51% -61.54%
Depreciation, Depletion And Amortization $318.0M
YoY Change 0.95%
Cash From Operating Activities $380.0M
YoY Change 84.47%
INVESTING ACTIVITIES
Capital Expenditures $79.00M
YoY Change 154.84%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$79.00M
YoY Change 163.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -424.0M
YoY Change 253.33%
NET CHANGE
Cash From Operating Activities 380.0M
Cash From Investing Activities -79.00M
Cash From Financing Activities -424.0M
Net Change In Cash -123.0M
YoY Change -319.64%
FREE CASH FLOW
Cash From Operating Activities $380.0M
Capital Expenditures $79.00M
Free Cash Flow $301.0M
YoY Change 72.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
365238917 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
365238917 shares
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
145000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-82000000 usd
us-gaap Profit Loss
ProfitLoss
-182000000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
364800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367400000 shares
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1000000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
37000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50000000 usd
CY2024Q2 bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
12000000 usd
CY2023Q2 bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
16000000 usd
bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
24000000 usd
bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
26000000 usd
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
83000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
60000000 usd
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
2014000000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
1755000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
3886000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
3524000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
389000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
412000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
670000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
587000000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
13000000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
350000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
319000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
705000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
626000000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
12000000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-21000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-26000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-31000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57000000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27000000 usd
us-gaap Profit Loss
ProfitLoss
-78000000 usd
us-gaap Profit Loss
ProfitLoss
-182000000 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11000000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-24000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
10000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-175000000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
364100000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
367100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
367400000 shares
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27000000 usd
us-gaap Profit Loss
ProfitLoss
-78000000 usd
us-gaap Profit Loss
ProfitLoss
-182000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-84000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
69000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-118000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
134000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-84000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
69000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-118000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
134000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-85000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
96000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-196000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-48000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-17000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-16000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-27000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-80000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
113000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-180000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-174000000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000000 usd
CY2024Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-84000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-227000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33000000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3000000 usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
27000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
69000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
271000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
69000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
18000000 usd
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
us-gaap Profit Loss
ProfitLoss
-78000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-118000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-227000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
260000000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
74000000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
15000000 usd
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
0 usd
us-gaap Profit Loss
ProfitLoss
-182000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
134000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
271000000 usd
us-gaap Profit Loss
ProfitLoss
-78000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
638000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
634000000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
28000000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
23000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50000000 usd
bhc Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
-6000000 usd
bhc Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
14000000 usd
bhc Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
32000000 usd
bhc Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
32000000 usd
bhc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-101000000 usd
bhc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-30000000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5000000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000 usd
bhc Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
-27000000 usd
bhc Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
0 usd
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
4000000 usd
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
2000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
69000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
74000000 usd
bhc Derivative Gain Excluded Component
DerivativeGainExcludedComponent
6000000 usd
bhc Derivative Gain Excluded Component
DerivativeGainExcludedComponent
6000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
bhc Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities
PaymentForDebtExtinguishmentOrDebtPrepaymentCostOperatingActivities
0 usd
bhc Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities
PaymentForDebtExtinguishmentOrDebtPrepaymentCostOperatingActivities
2000000 usd
bhc Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
5000000 usd
bhc Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
3000000 usd
bhc Amortization Interim Contract And Inventory Step From Acquisition
AmortizationInterimContractAndInventoryStepFromAcquisition
40000000 usd
bhc Amortization Interim Contract And Inventory Step From Acquisition
AmortizationInterimContractAndInventoryStepFromAcquisition
0 usd
bhc Foreign Currency Transaction And Other Gain Loss Before Tax
ForeignCurrencyTransactionAndOtherGainLossBeforeTax
18000000 usd
bhc Foreign Currency Transaction And Other Gain Loss Before Tax
ForeignCurrencyTransactionAndOtherGainLossBeforeTax
-21000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
135000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-55000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
176000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
160000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-119000000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
54000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
189000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-105000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
591000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
360000000 usd
bhc Payments To Acquire Businesses And For Other Investments
PaymentsToAcquireBusinessesAndForOtherInvestments
0 usd
bhc Payments To Acquire Businesses And For Other Investments
PaymentsToAcquireBusinessesAndForOtherInvestments
31000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
160000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75000000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
5000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9000000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
2000000 usd
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1000000 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
-6000000 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
-6000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-152000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-108000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
155000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
455000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
885000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
690000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
18000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
12000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
11000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-764000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-262000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-339000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
962000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
591000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
623000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588000000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
595000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
579000000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
28000000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
9000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
623000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588000000 usd
us-gaap Nature Of Operations
NatureOfOperations
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">DESCRIPTION OF BUSINESS </span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch Health Companies Inc. (the “Company” or “Bausch Health”) is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (“GI”), hepatology, neurology and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products and aesthetic medical devices, and, through its approximately 88% ownership of Bausch + Lomb Corporation (“Bausch + Lomb” or “B+L”), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic areas of eye health. The Company’s products are marketed directly or indirectly in approximately 90 countries.</span></div>
CY2024Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
90 country
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the unaudited Condensed Consolidated Financial Statements, management is required to make estimates and assumptions. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited Condensed Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the differences could be material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</span></div>
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1939000000 usd
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
3365000000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
3172000000 usd
CY2024Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2132000000 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1910000000 usd
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
2852000000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
2904000000 usd
CY2023Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1858000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
33000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3000000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3000000 usd
bhc Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
2000000 usd
bhc Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
3000000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
33000000 usd
bhc Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
292000000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
241000000 usd
bhc Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
Acquisition-related contingent consideration
bhc Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
Acquisition-related contingent consideration
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-6000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
15000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
5000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
17000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
14000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
1000000 usd
CY2024Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
269000000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
248000000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
39000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
50000000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
230000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
198000000 usd
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
543000000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
509000000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
104000000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
124000000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
965000000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
911000000 usd
CY2024Q2 us-gaap Inventory Gross
InventoryGross
1612000000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
1544000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27198000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22998000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4200000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
27262000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22509000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4753000000 usd
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
28901000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22998000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5903000000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
28965000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22509000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6456000000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
528000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
991000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
869000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
831000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
234000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
215000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
532000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4200000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
11547000000 usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
31000000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
493000000 usd
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-98000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
11183000000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
56000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
11127000000 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
5497000000 usd
CY2024Q2 bhc Accrued Product Rebate Current
AccruedProductRebateCurrent
1260000000 usd
CY2023Q4 bhc Accrued Product Rebate Current
AccruedProductRebateCurrent
1069000000 usd
CY2024Q2 bhc Accrued Product Return Current
AccruedProductReturnCurrent
390000000 usd
CY2023Q4 bhc Accrued Product Return Current
AccruedProductReturnCurrent
380000000 usd
CY2024Q2 bhc Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
366000000 usd
CY2023Q4 bhc Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
344000000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
315000000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
360000000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
224000000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
236000000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
78000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
47000000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
705000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
697000000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3338000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3133000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20398000000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
21660000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
21006000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
22388000000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
452000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
450000000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21208000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21938000000 usd
CY2024Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0800
CY2023Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0805
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
78000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
2370000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
757000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6823000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7168000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1609000000 usd
CY2024Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1593000000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
20398000000 usd
CY2024Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-1262000000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
21660000000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
74000000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
74000000 usd
CY2024Q2 bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
153000000 usd
CY2023Q2 bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
148000000 usd
bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
299000000 usd
bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
284000000 usd
CY2024Q2 bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
3000000 usd
CY2023Q2 bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
8000000 usd
bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
8000000 usd
bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
15000000 usd
CY2024Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
156000000 usd
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
156000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
307000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
299000000 usd
CY2024Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-21000000 usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
71000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-27000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
79000000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4000000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-17000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-6000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
14000000 usd
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000000 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5000000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000000 usd
CY2024Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1000000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
3000000 usd
CY2024Q2 bhc Other Income Expense Net
OtherIncomeExpenseNet
3000000 usd
CY2023Q2 bhc Other Income Expense Net
OtherIncomeExpenseNet
1000000 usd
bhc Other Income Expense Net
OtherIncomeExpenseNet
3000000 usd
bhc Other Income Expense Net
OtherIncomeExpenseNet
1000000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
83000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57000000 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
68000000 usd
bhc Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
-11000000 usd
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-12000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000000 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
39000000 usd
bhc Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
86000000 usd
us-gaap Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
41000000 usd
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
21000000 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
18000000 usd
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
7000000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2416000000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2254000000 usd
CY2024Q2 bhc Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
881000000 usd
CY2023Q4 bhc Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
918000000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
54000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
51000000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
410000000 usd
CY2024Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
27000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
10000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-54000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-175000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367900000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
364800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
364100000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2300000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2300000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
370200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
367100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
367400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
364100000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2024Q2 bhc Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
366000000 usd
CY2024Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
270000000 usd
CY2023Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
269000000 usd
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
544000000 usd
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
542000000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000000 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
37000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
6000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
50000000 usd
CY2024Q2 bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
12000000 usd
CY2023Q2 bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
16000000 usd
bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
24000000 usd
bhc Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
26000000 usd
CY2024Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20000000 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
83000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-20000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
60000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
389000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
412000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
670000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
587000000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
13000000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
350000000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
319000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
705000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
626000000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
12000000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23000000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-21000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-26000000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-31000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57000000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2403000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2167000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4556000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4111000000 usd
bhc Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
10 product
bhc Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
10 product
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2403000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2167000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4556000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4111000000 usd

Files In Submission

Name View Source Status
0000885590-24-000029-index-headers.html Edgar Link pending
0000885590-24-000029-index.html Edgar Link pending
0000885590-24-000029.txt Edgar Link pending
0000885590-24-000029-xbrl.zip Edgar Link pending
bhc-20240630.htm Edgar Link pending
bhc-20240630.xsd Edgar Link pending
exhibit102-employeematters.htm Edgar Link pending
bhc-20240630_cal.xml Edgar Link unprocessable
bhc-20240630_def.xml Edgar Link unprocessable
bhc-20240630_lab.xml Edgar Link unprocessable
bhc-20240630_pre.xml Edgar Link unprocessable
bhc-20240630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
exhibit311q22024.htm Edgar Link pending
exhibit312q22024.htm Edgar Link pending
exhibit321q22024.htm Edgar Link pending
exhibit322q22024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending